Adamas Announces New Employment Inducement Grant

Rhea-AI Summary

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) has announced the granting of restricted stock units (RSUs) to five new employees, totaling 58,500 shares. These RSUs will vest over a period of three years, as per the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was established to attract new talent. This move reflects the company's commitment to incentivizing and retaining skilled professionals to enhance its focus on developing innovative treatments for neurological diseases.

Positive

• Granting of 58,500 restricted stock units to new employees as an incentive to attract talent.
• RSUs vesting over three years could enhance employee retention and motivation.

Negative

• None.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted five new employees restricted stock units to acquire 58,500 shares of the company’s common stock. The restricted stock units vest over three years and were granted pursuant to the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was approved by the company's board of directors in March 2016 under Rule 5653(c)(4) of the Nasdaq Global Market for equity grants to induce new employees to enter into employment with the company.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases.

Source: Adamas Pharmaceuticals, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210507005113/en/

FAQ

What recent action did Adamas Pharmaceuticals take regarding employee compensation?

Adamas Pharmaceuticals announced the granting of 58,500 restricted stock units to five new employees, vesting over three years.

How many shares were granted as restricted stock units by Adamas Pharmaceuticals?

A total of 58,500 shares were granted as restricted stock units.

What is the purpose of the restricted stock units granted by Adamas Pharmaceuticals?

The restricted stock units aim to incentivize and attract new employees to the company.

Under which plan were the restricted stock units granted by Adamas Pharmaceuticals?

The restricted stock units were granted under the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan.